First human trials of designer protein therapies stun US neuroscientists
Chinese researchers are testing DREADDs, a gene therapy to turn down neuronal activity, in the clinic
Summary
Chinese researchers are conducting the first human trials of DREADDs, a gene therapy designed to modulate neuronal activity. The results have caught the attention of US neuroscientists, highlighting a significant advancement in the potential treatment of neurological conditions.
Comments (36 of ) ⌛